Innovation and Access to Medicines: A Case Study for HIV/AIDS and Hepatitis C - Gregg Alton, Gilead Sciences Inc.
| Code du document | WIPO/GC/INN/GE/14/T2 |
| Réunion(s) connexe(s) | WIPO/GC/INN/GE/14 |
| Date de publication | 10 décembre 2014 |
| English | Innovation and Access to Medicines: A Case Study for HIV/AIDS and Hepatitis C - Gregg Alton, Gilead Sciences Inc. |